Published in Brain Dev on November 23, 1993
Male reproductive health and environmental xenoestrogens. Environ Health Perspect (1996) 4.11
The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins. Neuron (1993) 2.67
Noninvasive MRI thermometry with the proton resonance frequency (PRF) method: in vivo results in human muscle. Magn Reson Med (1995) 2.40
Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging (1994) 2.27
Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum (1999) 2.12
Impaired autoregulation of cerebral blood flow in the distressed newborn infant. J Pediatr (1979) 2.07
Antimetabolic antibodies to Mycoplasma pneumoniae measured by tetrazolium reduction inhibition. Proc Soc Exp Biol Med (1966) 2.01
Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med (1990) 1.99
Nordic consensus on treatment of undescended testes. Acta Paediatr (2007) 1.99
Current status of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg (2000) 1.94
Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. Mol Pharmacol (2001) 1.73
CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding. Mol Pharmacol (1999) 1.73
Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiol (2007) 1.72
Elongation factor 2. Amino acid sequence at the site of adenosine diphosphate ribosylation. J Biol Chem (1974) 1.70
In vivo assessment of mutations in the phenylalanine hydroxylase gene by phenylalanine loading: characterization of seven common mutations. Eur J Pediatr (1995) 1.69
Phaseotoxin A: an antimetabolite from Pseudomonas phaseolicola. Biochem Biophys Res Commun (1976) 1.63
Magnetic resonance imaging, radiography, and scintigraphy of the finger joints: one year follow up of patients with early arthritis. The TIRA Group. Ann Rheum Dis (2000) 1.61
[Potency, fertility and sex hormones in young male epileptics]. Ugeskr Laeger (1975) 1.61
Intrauterine growth retardation and premature delivery: the influence of maternal smoking and psychosocial factors. Am J Public Health (1996) 1.59
Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ (2000) 1.47
Changes in synovial membrane and joint effusion volumes after intraarticular methylprednisolone. Quantitative assessment of inflammatory and destructive changes in arthritis by MRI. J Rheumatol (1996) 1.43
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study. Br J Cancer (2013) 1.42
31P magnetic resonance spectroscopy of skeletal muscle in patients with fibromyalgia. J Rheumatol (1992) 1.41
Wine for type 2 diabetic patients? Diabet Med (1993) 1.41
An inactivated mycoplasma pneumoniae vaccine. JAMA (1965) 1.40
A controlled comparison of myelography, computed tomography, and magnetic resonance imaging in clinically suspected lumbar disc herniation. Spine (Phila Pa 1976) (1995) 1.40
[Magnetic resonance in choledocholithiasis]. Ugeskr Laeger (2000) 1.39
Effects of recombinant human erythropoietin on the haemopoietic bone marrow monitored by magnetic resonance spectroscopy in patients with end-stage renal disease. Magn Reson Imaging (1990) 1.39
Pulsatile brain movement and associated hydrodynamics studied by magnetic resonance phase imaging. The Monro-Kellie doctrine revisited. Neuroradiology (1992) 1.39
[Volumes of synovial membrane and joint effusion determined by MR imaging. Markers of severity and/or activity in rheumatoid arthritis?]. Ugeskr Laeger (1997) 1.38
Medical, social and occupational history as risk indicators for low-back trouble in a general population. Spine (Phila Pa 1976) (1986) 1.37
Gaba derivative in spasticity. (Beta-(4-chlorophenyl)-gamma-aminobutyric acid, Ciba 34.647-Ba). Acta Neurol Scand (1970) 1.35
Serologic response to Mycoplasma pneumoniae infection. I. Evaluation of immunofluorescence, complement fixation, indirect hemagglutination, and tetrazolium reduction inhibition tests for the diagnosis of infection. Am J Epidemiol (1966) 1.34
Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain (2008) 1.31
Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) (2005) 1.30
Bone loss in unclassified polyarthritis and early rheumatoid arthritis is better detected by digital x ray radiogrammetry than dual x ray absorptiometry: relationship with disease activity and radiographic outcome. Ann Rheum Dis (2004) 1.28
In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. Magn Reson Imaging (1993) 1.28
Visual activation in infants and young children studied by functional magnetic resonance imaging. Pediatr Res (1998) 1.27
Nucleic acid-induced resistance to viral infection. J Bacteriol (1965) 1.27
Phonon dispersion in graphite. Phys Rev Lett (2004) 1.26
Assessment of demyelination, edema, and gliosis by in vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis. Magn Reson Med (1989) 1.23
MR diffusion imaging of human intracranial tumours. Neuroradiology (1997) 1.23
Serious life events and congenital malformations: a national study with complete follow-up. Lancet (2000) 1.22
the central nervous system in Fabry's disease. A clinical, pathological, and biochemical investigation. Arch Neurol (1971) 1.20
Local sympathetic reflex mechanism in regulation of blood flow in human subcutaneous adipose tissue. Acta Physiol Scand Suppl (1977) 1.20
Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med (1996) 1.19
The component fragments obtained by acid dissociation of papain-solubilized H-2 molecules. J Immunogenet (1976) 1.18
Pathological changes in the central and peripheral nervous system of young long-term diabetics. II. The spinal cord and peripheral nerves. Diabetologia (1968) 1.17
Fiber types in the striated urethral and anal sphincters. Acta Neuropathol (1983) 1.17
Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia (1996) 1.16
Klinefelter's syndrome and trisomy 18 in a newborn boy. Clin Genet (1978) 1.15
Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia (1996) 1.13
Cardiac involvement in juvenile amaurotic idiocy--a specific heart muscle disorder. Histological findings in 13 autopsied patients. Acta Pathol Microbiol Scand A (1981) 1.12
Functional MRI of CO2 induced increase in cerebral perfusion. NMR Biomed (1994) 1.12
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Ultrasonography in arthritis of the knee. A comparison with MR imaging. Acta Radiol (1995) 1.10
Modified tecnique of muscle biopsy. Acta Pathol Microbiol Scand (1969) 1.09
Identification of patients with hereditary haemochromatosis by magnetic resonance imaging and spectroscopic relaxation time measurements. Magn Reson Imaging (1992) 1.09
Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch Neurol (1984) 1.09
In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magn Reson Med (1988) 1.08
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
Myocardial perfusion modeling using MRI. Magn Reson Med (1996) 1.07
Subacute dysautonomia with incomplete recovery. Acta Neurol Scand (1972) 1.07
Local reflex in microcirculation in human skeletal muscle. Acta Physiol Scand (1977) 1.07
On the pathogenesis of regional cerebral ischemia in intracranial hemorrhage: a causal influence of potassium? Pediatr Res (1986) 1.07
Perinatal hypoxic-ischemic brain damage and intraventricular hemorrhage. A pathogenetic model. Arch Neurol (1980) 1.06
[Hudegården and its underground clinic]. Ugeskr Laeger (1970) 1.06
Functional magnetic resonance imaging of the normal and abnormal visual system in early life. Neuropediatrics (2000) 1.05
Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist. J Pharmacol Exp Ther (1997) 1.05
Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76 TeV. Phys Rev Lett (2011) 1.05
Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women. Environ Int (2013) 1.05
Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents. Eur J Pediatr (1985) 1.04
Low cerebral blood flow in hypotensive perinatal distress. Acta Neurol Scand (1977) 1.04
Quantification of aortic regurgitation by magnetic resonance velocity mapping. Am Heart J (1993) 1.04
The cancer information service research consortium: an emerging laboratory for cancer control research. Prev Med (1998) 1.04
Scoring of synovial membrane hypertrophy and bone erosions by MR imaging in clinically active and inactive rheumatoid arthritis of the wrist. Scand J Rheumatol (1995) 1.04
Theoretical and experimental evaluation of phase-dispersion effects caused by brain motion in diffusion and perfusion MR imaging. J Magn Reson Imaging (1997) 1.03
Childhood physical abuse, early social support, and risk for maltreatment: current social support as a mediator of risk for child physical abuse. Child Abuse Negl (2001) 1.03
Plasma exchange combined with azathioprine in multiple sclerosis using serial gadolinium-enhanced MRI to monitor disease activity: a randomized single-masked cross-over pilot study. Neurology (1996) 1.03
The effects of refractory epilepsy on intellectual functioning in children and adults. A longitudinal study. Seizure (2001) 1.03
Absolute quantitative proton NMR spectroscopy based on the amplitude of the local water suppression pulse. Quantification of brain water and metabolites. NMR Biomed (1994) 1.03
Local nervous mechanism in regulation of blood flow in human subcutaneous tissue. Acta Physiol Scand (1976) 1.03
The synthesis of new adenosine A3 selective ligands containing bioisosteric isoxazoles. Bioorg Med Chem Lett (1998) 1.02
Comparison of dual X-ray absorptiometry (DXA), digital X-ray radiogrammetry (DXR), and conventional radiographs in the evaluation of osteoporosis and bone erosions in patients with rheumatoid arthritis. Scand J Rheumatol (2005) 1.02
Activity of polyadenosine diphosphoribose polymerase during the human cell cycle. Biochem Biophys Res Commun (1971) 1.01
Texture analysis in quantitative MR imaging. Tissue characterisation of normal brain and intracranial tumours at 1.5 T. Acta Radiol (1995) 1.01
Pressure passive cerebral blood flow and breakdown of the blood-brain barrier in experimental fetal asphyxia. Acta Paediatr Scand (1979) 1.01
History of the Cancer Information Service. J Natl Cancer Inst Monogr (1993) 1.01
In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis. Magn Reson Imaging (1992) 1.01